AlbionVC

📢 𝐀𝐥𝐛𝐢𝐨𝐧𝐕𝐂 & 𝐇𝐋𝐓𝐇 𝐄𝐮𝐫𝐨𝐩𝐞 𝐇𝐞𝐚𝐥𝐭𝐡𝐭𝐞𝐜𝐡 𝐌𝐚𝐫𝐤𝐞𝐭 𝐌𝐚𝐩 𝟐𝟎𝟐𝟓 𝐢𝐬 𝐋𝐈𝐕𝐄 💥 The 4th AlbionVC European healthtech market map is now live, this time in partnership with HLTH Europe. Having analysed over 5,000 European companies across digital care and digital pharma, we’ve identified startups that are transforming the European healthcare ecosystem and continuously pushing the boundaries of modern care delivery and research. This year’s map focuses on companies that were founded in or after 2015, have raised institutional funding in the last 3 years, and have over 10 employees. Original data set was provided by Dealroom.co and analysed by the AlbionVC healthcare team Molly Gilmartin, Christoph Ruedig, Leigh Brody, Andrew Elder. In 2025 European healthcare proves that AI is not just a buzzword, but a growth engine. Emerging trends: #DigitalCare: LLMs are transforming clinical workflows—from note-taking to decision support—enabling faster, smarter care. Nearly 50 new startups have entered the space in just 18 months! 𝐕𝐢𝐫𝐭𝐮𝐚𝐥-𝐟𝐢𝐫𝐬𝐭 𝐜𝐚𝐫𝐞 is a new market segment within digital care in 2025 that brings together multiple digital health services into unified, condition-specific care pathways. About half of the companies in the segment are operating B2C models thus driving consumerisation of healthcare #TechBio: AI is now embedded in the drug discovery pipeline. A new generation of 25 startups is targeting previously untreatable diseases 🟢 𝐅𝐮𝐥𝐥 𝐥𝐢𝐬𝐭 𝐨𝐟 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐚𝐧𝐝 𝐚𝐧 𝐢𝐧𝐭𝐞𝐫𝐚𝐜𝐭𝐢𝐯𝐞 𝐯𝐞𝐫𝐬𝐢𝐨𝐧 𝐡𝐞𝐫𝐞: https://lnkd.in/da6H84sJ As European healthtech continues to scale, it is possible that we’ve missed a number of high-growth startups. If you’d like to get added to the map please fill in this short form https://lnkd.in/eBW7xj7T #Healthtech #DigitalCare #DigitalPharma #TechBio #AI #healthcare #Europeanhealth 

𝐖𝐡𝐲 𝐭𝐡𝐞 𝐔𝐊 𝐧𝐞𝐞𝐝𝐬 𝐌𝐚𝐝𝐞 𝐢𝐧 𝐁𝐫𝐢𝐭𝐚𝐢𝐧 𝐜𝐨𝐦𝐩𝐮𝐭𝐞 In the 20th century, nations fought over oil. In the 21st, it’s compute. Whoever controls it sets the pace in AI and captures the economic upside. AlbionVC Partner Dave Grimm lays out in Sifted why the UK must act now — and what it takes to turn Britain into a true AI maker, not just a renter: 𝐅𝐢𝐯𝐞 𝐫𝐞𝐚𝐬𝐨𝐧𝐬 𝐰𝐞 𝐧𝐞𝐞𝐝 𝐌𝐚𝐝𝐞-𝐢𝐧-𝐁𝐫𝐢𝐭𝐚𝐢𝐧 𝐜𝐨𝐦𝐩𝐮𝐭𝐞: 1️⃣ Sovereignty & resilience – relying on foreign chips means relying on foreign politics. 2️⃣ World-class research base – four of the world’s top ten universities are British. 3️⃣ Rising startup ecosystem – UK compute ventures have raised £1.5bn since 2015, with scale-up rounds accelerating. 4️⃣ Government as anchor customer – revenue beats rhetoric; early procurement can unlock growth cycles. 5️⃣ A new growth engine – defensible IP, exportable hardware, high-wage jobs, and global leverage. Britain has the science, the companies and the talent. What’s missing is bold action to build sovereign compute capacity on UK IP. 👉 Read Dave’s full opinion piece here: https://lnkd.in/dC3Hcjxc #Compute #DeepTech #AI #MadeInBritain #TechSovereignty #FutureOfCompute #DeepTechUK #AIInfrastructure #InnovationEcosystem

𝐁𝐮𝐢𝐥𝐝𝐢𝐧𝐠 𝐭𝐡𝐞 𝐈𝐧𝐟𝐫𝐚𝐬𝐭𝐫𝐮𝐜𝐭𝐮𝐫𝐞 𝐁𝐞𝐡𝐢𝐧𝐝 𝐭𝐡𝐞 𝐅𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐅𝐢𝐱𝐞𝐝 𝐈𝐧𝐜𝐨𝐦𝐞 We first backed TransFICC in 2017 with a conviction that infrastructure for fixed income trading was ripe for transformation. Today, they serve global tier-one banks, hedge funds, and asset managers—enabling ultra-low latency connectivity, automated workflows, and a shift away from fragmented legacy systems. Following their $25M Series B, Cat McDonald, AlbionVC Partner, sat down with CEO & Co-founder Steve Toland to reflect on the company’s journey, culture, and long-term vision: 🖱️ Built on customer need: The idea came directly from a bank struggling with slow, costly venue integrations. 📀 A culture of engineering excellence: Daily customer releases, no-bugs policy, and test-driven development from day one. 📄 From $25K prototypes to winning Citi: Enterprise sales done creatively, credibly, and early. 📒 Scaling with intention: Doubling headcount gradually while preserving technical quality and company culture. 📐 Reliability at the core: 99.9% uptime SLAs, accepted “as is” by major banks. 🔑 Playing the long game: In a lumpy, high-trust market, sustainable growth and investor alignment matter more than hype. TransFICC’s journey shows that in fixed income, the real edge is built on trust, uptime, and engineering excellence. More here: https://lnkd.in/dX-fNFfF #Fintech #CapitalMarkets #EnterpriseTech #AlbionVC #FounderJourney #TransFICC #FixedIncome #Infrastructure #DeepTech #SeriesB

Innerworks, pioneers of Synthetic Threat Intelligence, has raised $4M in a seed round led by us at AlbionVC, with participation from top investors including Digital Currency Group, Founders Capital, Firestreak Ventures, NVTBL Ventures, Metaversal Ventures, and senior leaders from Crypto.com, Citi, UBS, Coinbase, Checkout.com, and Apple. Innerworks has developed the first platform capable of distinguishing authentic human behaviour from AI-generated interactions, achieving a 97% detection rate—outperforming multibillion-dollar incumbents. Its technology is already protecting financial institutions and digital asset platforms, including zeroShadow in the investigation of the $1.5bn ByBit hack. AlbionVC Partner Cat McDonald said: “We invested in Innerworks because they’re not incrementally improving fraud detection, they’re fundamentally reimagining it. Their ability to detect what other systems misrepresents; an essential new security layer for the financial sector’s response to this new threat“. Cat has more on why we invested in Innerworks here: https://lnkd.in/epKtxikM The funding will accelerate product development, expand the RedTeam ecosystem, and scale Innerworks’ presence across global financial centres, helping protect user ecosystems online against increasingly sophisticated AI threats. Congratulations to founders Oliver Quie (CEO), Oscar Hayek (CTO), and Tom Ryan (CPO) and the whole team at Innerworks! Read the full press release here: https://lnkd.in/eHFhD2qr #AIInnovation #CyberSecuritySolutions #FinTechInnovation #FraudDetection #SyntheticIntelligence #VentureCapital #Funding #DigitalSecurity #EmergingTech

A pioneering milestone in gene therapy has been reached at Great Ormond Street Hospital for Children NHS Foundation Trust (GOSH) and the UCL Great Ormond Street Institute of Child Health (UCL GOSH ICH). The first-ever clinical trial for patients with the rare immunodeficiency 𝗽𝟰𝟳 𝗖𝗵𝗿𝗼𝗻𝗶𝗰 𝗚𝗿𝗮𝗻𝘂𝗹𝗼𝗺𝗮𝘁𝗼𝘂𝘀 𝗗𝗶𝘀𝗲𝗮𝘀𝗲 (𝗖𝗚𝗗) is now underway, with the inaugural patient, Remi, showing life-changing results. Following treatment, he has been able to resume his studies and is preparing to begin university. This world-first gene therapy was developed, manufactured, and delivered entirely under one roof at the Zayed Centre for Research into Rare Diseases in Children—marking a true bench-to-bedside achievement. We are proud that the UCL Technology Fund, managed by us at AlbionVC in collaboration with UCL Business Ltd, has funded the vector development, preclinical testing, and ongoing clinical trial of this breakthrough therapy. This achievement underscores the importance of sustained investment in translational research, ensuring that innovations in the laboratory can be brought to patients with rare diseases as swiftly and effectively as possible. More on the The Times: https://lnkd.in/e-TiZEwd Simon Goldman #GeneTherapy #LifeSciences #Innovation #UCLTF #RareDiseases #MedicalInnovation #TranslationalResearch #HealthcareInnovation #FutureOfMedicine #Biotech

🤖 Neurosymbolic AI, the powerful hybrid of large language models and symbolic reasoning, is moving from research to real-world impact.   Our backed company Imandra is at the forefront of this shift, helping organisations like Amazon build AI systems that reason with accuracy, minimise hallucinations, and operate at scale.   Co-founder and Co-CEO Grant Olney Passmore puts it best: “Neurosymbolic AI is the solution because it combines the statistical modeling of LLMs with the axiomatic, logical approach of symbolic reasoning.”   From finance to defence, Imandra’s approach is shaping the next era of reliable AI. 🔗 Read more in the The Wall Street Journal: https://lnkd.in/eEg_XcRT #AI #NeurosymbolicAI #Portfolio #DeepTech #FutureOfAI #ArtificialIntelligence #MachineLearning #Innovation #LLMs

📢𝐇𝐮𝐦𝐚𝐧𝐥𝐨𝐨𝐩 𝐣𝐨𝐢𝐧𝐬 𝐀𝐧𝐭𝐡𝐫𝐨𝐩𝐢𝐜💥 We’re thrilled to see Raza Habib, Peter Hayes, and Jordan Burgess—and their exceptional team at Humanloop —joining forces with a leading voice in AI safety and innovation. From our initial support via the UCL Technology Fund, Humanloop’s vision to make AI more accessible, accurate, and human-centric has continually impressed us. Anthropic’s decision to bring on board Humanloop’s team underscores not just their technical expertise, but their commitment to building AI that enhances rather than replaces human capability. We look forward to seeing how their collaboration accelerates the pace and safety of AI development. Wishing the entire team every success as they embark on this exciting new journey at Anthropic. More here: https://humanloop.com/ #ArtificialIntelligence #AI #AIFuture #AIDevelopment #GenerativeAI #AIInnovation #AISafety #Acquisition #TechNews

Why more doctors are leaving the NHS for healthtech — and why that’s not a bad thing The rise in clinicians leaving frontline medicine might be alarming but as Dr Molly Gilmartin (Investment Director AlbionVC and former doctor) argues on LBC Opinion, many are actually reinventing how they contribute. Here’s what’s driving the shift and why it matters: 🏥 Firsthand insight: Clinician-founders have lived the pressures of the NHS, which gives them a unique understanding of what solutions are truly practical 🥼 Different routes to impact: Outside of clinical practice, doctors are building and joining startups to solve the problems they once faced daily 🩺 Faster innovation: The pace of daily NHS work can make it hard to test and scale new ideas. Startups can experiment and bring solutions to market more quickly, often in partnership with the NHS. 🤝 Patient-centred focus: Many of these ventures address underserved areas such as women’s health, working directly with patient communities to design better tools and services 👩⚕️ Collaboration over separation: Reformers inside the NHS and builders outside can, together, create a better healthcare system The future of healthcare will depend on strong collaboration between those delivering care today and those designing the tools of tomorrow. More on LBC (Global) here: https://lnkd.in/dQWcEy3m #HealthTech #Innovation #NHS #ClinicianFounders #HealthcareLeadership #LBC

What does it really take to build successful university spinouts? In this episode of Lab to Market Leadership, AlbionVC Partner Dave Grimm shares with Chris Reichhelm how a decade-long partnership with UCL is rewriting the rules for academic entrepreneurship. Dave reveals the playbook behind successful Deeptech spinouts like Phasecraft and Oriole Networks — from standardising deal terms to prioritising pace over perfection, and introducing a more founder-friendly equity model. Key topics include: 🤝 Building better university-VC partnerships — what works and what doesn’t 🧮 A new equity model — how the 5% structure reshaped UCL’s spinout success 🤼 Founding team dynamics — from CEO transitions to the right founder archetypes 🚲 Pace over patents — why speed, not IP, drives real progress 📈 Scaling UK Deeptech — fixing the talent gap, pension funding, and procurement A must-listen for founders, tech transfer teams, and policymakers, watch the full Podcast episode here: https://lnkd.in/evznyy39 #Deeptech #UniversitySpinouts #VC #AlbionVC #TechTransfer #Innovation #ScaleUpUK #LabToMarket #Podcast

𝐖𝐡𝐲 𝐋𝐨𝐧𝐝𝐨𝐧 𝐒𝐭𝐢𝐥𝐥 𝐋𝐞𝐚𝐝𝐬 – 𝐀𝐧𝐝 𝐖𝐡𝐲 𝐓𝐡𝐚𝐭’𝐬 𝐆𝐨𝐨𝐝 𝐟𝐨𝐫 𝐄𝐮𝐫𝐨𝐩𝐞 Paris is rising fast as a global tech hub and reflects the growing strength of Europe’s tech ecosystem as a whole. And within it, London remains the leading hub.    In the August issue of Entrepreneur Magazine UK, AlbionVC Partner Ed Lascelles explores why London remains the continent’s deep tech powerhouse — and why it’s only getting stronger, with a mix of:   🔵 cutting-edge academic research (think Oxford–Cambridge–London triangle), 🔴 deep pools of investor and operator experience, and ⚪ increasing ability to scale companies from the UK London holds a long-term advantage the convergence of science, software and scaling know-how gives London a leading edge in Europe’s deep tech landscape. And as long as London continues to evolve, collaborate and lead with ambition, it will remain one of the defining engines of European tech.   Read Ed’s full perspective here: https://lnkd.in/euVgfsWQ #DeepTech #StartupEcosystem #VC #LondonTech #EuropeanInnovation #Spinouts #AcademicToStartUp #Entrepreneur